Fortress Biotech, Inc. (FBIO)
2.72
+0.04
(+1.49%)
USD |
NASDAQ |
Sep 02, 10:40
Fortress Biotech Net Income (TTM) : 141.19M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 141.19M |
| March 31, 2026 | 128.94M |
| December 31, 2025 | -32.92M |
| September 30, 2025 | -53.83M |
| June 30, 2025 | -89.35M |
| March 31, 2025 | -106.52M |
| December 31, 2024 | -120.86M |
| September 30, 2024 | -123.52M |
| June 30, 2024 | -107.56M |
| March 31, 2024 | -138.03M |
| December 31, 2023 | -154.15M |
| September 30, 2023 | -182.62M |
| June 30, 2023 | -224.95M |
| March 31, 2023 | -219.58M |
| December 31, 2022 | -213.91M |
| September 30, 2022 | -224.98M |
| June 30, 2022 | -217.78M |
| March 31, 2022 | -188.24M |
| December 31, 2021 | -164.83M |
| September 30, 2021 | -116.81M |
| June 30, 2021 | -100.91M |
| March 31, 2021 | -104.98M |
| December 31, 2020 | -102.98M |
| September 30, 2020 | -115.45M |
| June 30, 2020 | -110.46M |
| Date | Value |
|---|---|
| March 31, 2020 | -109.47M |
| December 31, 2019 | -101.66M |
| September 30, 2019 | -99.94M |
| June 30, 2019 | -103.76M |
| March 31, 2019 | -112.42M |
| September 30, 2018 | -122.18M |
| June 30, 2018 | -127.26M |
| March 31, 2018 | -121.42M |
| December 31, 2017 | -99.84M |
| September 30, 2017 | -95.12M |
| June 30, 2017 | -75.77M |
| March 31, 2017 | -69.21M |
| December 31, 2016 | -71.29M |
| September 30, 2016 | -65.06M |
| June 30, 2016 | -67.96M |
| March 31, 2016 | -57.99M |
| December 31, 2015 | -53.88M |
| September 30, 2015 | -42.52M |
| June 30, 2015 | -27.26M |
| March 31, 2015 | -25.55M |
| December 31, 2014 | -20.39M |
| September 30, 2014 | -26.47M |
| June 30, 2014 | -29.71M |
| March 31, 2014 | -35.67M |
| December 31, 2013 | -37.16M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | -67.43M |
| Ironwood Pharmaceuticals, Inc. | 129.87M |
| Kura Oncology, Inc. | -296.78M |
| Spero Therapeutics, Inc. | 7.383M |
| Cue Biopharma, Inc. | -164.11M |